TARS Tarsus Pharmaceuticals

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025

IRVINE, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 5:00 a.m. PT / 8:00 a.m. ET on Tuesday, February 25, 2025, to report its fourth quarter and full-year 2024 financial results and provide a corporate update.

Participants may access the webcast . A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.

About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution, 0.25%) is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease.

Media Contact:

Adrienne Kemp

Sr. Director, Corporate Communications

(949) 922-0801

Investor Contact:

David Nakasone

Head of Investor Relations

(949) 620-3223



EN
20/02/2025

Underlying

TARSTarsus Pharmaceuticals

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tarsus Pharmaceuticals

 PRESS RELEASE
Free
TARS Tarsus Pharmace...

Tarsus to Participate in Upcoming Investor Conference

Tarsus to Participate in Upcoming Investor Conference IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference on Tuesday, March 11th, at 8:00 a.m. / 11:00 a.m. ET. A live webcast and additional information can be accessed on the events section of the Tarsus . The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time. About Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals, In...

4h / 6m 1 EN
 PRESS RELEASE
Free
TARS Tarsus Pharmace...

Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Resu...

Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements Generated fourth quarter and full-year 2024 net product sales of XDEMVY® of $66.4 million and $180.1 million, respectively, during the first full year of launch Presented groundbreaking XDEMVY data; first pharmacologic treatment to demonstrate functional improvements in Meibomian Gland Disease and patient symptoms in Demodex blepharitis patients Continued advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, the next category-creating opportunity i...

February 25, 2025 1 EN
 PRESS RELEASE
Free
TARS Tarsus Pharmace...

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results o...

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025 IRVINE, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 5:00 a.m. PT / 8:00 a.m. ET on Tuesday, February 25, 2025, to report its fourth quarter and full-year 2024 financial results and provide a corporate update. Participants may access the webcast . A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately ...

February 20, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 46.29
OSK OSHKOSH CORP
VIAV Viavi Solutions... ... (+38)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

OSK OSHKOSH CORP
VIAV VIAVI SOLUTIONS INC
ROLL RBC BEARINGS INCORPORATED
NRIM NORTHRIM BANCORP INC.
KEYS KEYSIGHT TECHNOLOGIES INC
JBT JOHN BEAN TECHNOLOGIES CORPORATION
GLW CORNING INC
EMN EASTMAN CHEMICAL COMPANY
CIEN CIENA CORPORATION
CAMT CAMTEK LTD.
BMI BADGER METER INC.
BEN FRANKLIN RESOURCES INC.
TATT TAT TECHNOLOGIES LTD.
INTT INTEST CORP.
PLSE PULSE BIOSCIENCES
LCUT LIFETIME BRANDS
ISSC INNOVATIVE SOLUTIONS & SUPPORT INC.
SRTS SENSUS HEALTHCARE
FTG111 FLATEXDEGIRO AG
CVCO CAVCO INDUSTRIES INC.
ATGE ADTALEM GLOBAL EDUCATION INC.
JHG JANUS HENDERSON GROUP PLC
BKR BAKER HUGHES COMPANY CLASS A
INS INTELLIGENT SYSTEMS CORP.
AVGO BROADCOM INC.
CSPI CSP INC.
TSSI TSS INC
INMB INMUNE BIO
TARS TARSUS PHARMACEUTICALS
HIMS HIMS AND HERS HEALTH INC (A)
GTLB GITLAB INC
VERV VERVE THERAPEUTICS INC
LNSR LENSAR INC
TEAM ATLASSIAN CORPORATION
BKSY BLACKSKY TECHNOLOGY INC
BBCN39 JPMORGAN BETABUILDERS CANADA BDR
VATE INNOVATE CORP
MNPR MONOPAR THERAPEUTICS INC.
02/03/25 February 3, 2025 1 EN
 PRESS RELEASE
Free
TARS Tarsus Pharmace...

Tarsus to Participate in Upcoming Investor Conferences

Tarsus to Participate in Upcoming Investor Conferences IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in fireside chats at two upcoming investor conferences: The Guggenheim SMID Cap Biotech Conference on Thursday, February 6th, at 6:00 a.m. PT / 9:00 a.m. ETThe Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12th, at 7:00 a.m. PT / 10:00 a.m. ET A live webcast and additional information can be accessed on the events section of the Tarsus . The replay will b...

January 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch